Biogen will charge $56,000-a-year for Alzheimer’s drug
Price over double the highest industry analyst estimate triggers renewed criticism
Pharma group Amarin sues FDA over right to brief doctors on drug
Dublin group says regulator refusal to allow it discuss off label use breaches US first amendment rights and puts it at a disadvantage to rival unregulated products
YOU MAY ALSO LIKE...
Crosswords & Puzzles
Crosswords & puzzles to keep you challenged and entertained
Stardust
Inquests into the nightclub fire that led to the deaths of 48 people
Common Ground
How does a post-Brexit world shape the identity and relationship of these islands
Family NoticesOpens in new window
Weddings, Births, Deaths and other family notices